Your browser doesn't support javascript.
loading
Acute metformin induces hyperglycemia in healthy adult mourning doves, Zenaida macroura.
Basile, Anthony J; Kreisler, Avin; Hassen, Ryan; Singh, Kavita; Symes, Maggie; Larson, Gale; de Sousa, Milena Figueiredo; Sweazea, Karen L.
Afiliación
  • Basile AJ; Center for Evolution and Medicine, Arizona State University, Tempe, AZ, United States of America; School of Life Sciences, Arizona State University, Tempe, AZ, United States of America.
  • Kreisler A; School of Life Sciences, Arizona State University, Tempe, AZ, United States of America.
  • Hassen R; School of Life Sciences, Arizona State University, Tempe, AZ, United States of America.
  • Singh K; School of Life Sciences, Arizona State University, Tempe, AZ, United States of America.
  • Symes M; College of Health Solutions, Arizona State University, Phoenix, AZ, United States of America.
  • Larson G; School of Life Sciences, Arizona State University, Tempe, AZ, United States of America.
  • de Sousa MF; College of Health Solutions, Arizona State University, Phoenix, AZ, United States of America.
  • Sweazea KL; Center for Evolution and Medicine, Arizona State University, Tempe, AZ, United States of America; College of Health Solutions, Arizona State University, Phoenix, AZ, United States of America. Electronic address: Karen.Sweazea@asu.edu.
Article en En | MEDLINE | ID: mdl-38311294
ABSTRACT
Birds have the highest blood glucose among vertebrates. Several mechanisms may explain this including the lack of a functional insulin-responsive glucose transport protein, high glucagon concentrations, and reliance on lipid oxidation resulting in the production of gluconeogenic precursors. The hypothesis was that interruption of gluconeogenesis using the diabetes medication metformin would lower glucose concentrations in wild-caught birds. We captured two cohorts of adult mourning doves, Zenaida macroura, and acclimated them to captivity for two weeks. In this crossover study, cohort 1 was administered a single dose of one of the following oral treatments each week metformin (150 or 300 mg/kg), glycogenolysis inhibitor (2.5 mg/kg 1,4-dideoxy-1,4-imino-D-arabinitol (DAB)), or water (50 µL). Whole blood glucose was measured using a glucometer at baseline, 30, 60, and 120 min following the oral doses. In contrast to mammals and chickens, 300 mg/kg metformin did not alter blood glucose (p > 0.05) whereas 150 mg/kg metformin increased blood glucose compared to water (p = 0.043). To examine whether 150 mg/kg metformin stimulated glycogenolysis, we co-administered 150 mg/kg metformin and 2.5 mg/kg DAB, which prevented the hyperglycemic response. Cohort 2 was administered the same treatments and the early response was examined (0, 5, 10, 15 min). Low-dose metformin increased blood glucose within 5 min (p = 0.039) whereas the high dose had no effect. DAB did not prevent the early response to metformin nor did it alter blood glucose concentrations when administered alone (p = 0.887). In conclusion, metformin increases endogenous blood glucose via glycogenolysis in healthy adult male mourning doves.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiperglucemia / Metformina Límite: Animals / Humans / Male Idioma: En Revista: Comp Biochem Physiol A Mol Integr Physiol Asunto de la revista: BIOLOGIA MOLECULAR / FISIOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiperglucemia / Metformina Límite: Animals / Humans / Male Idioma: En Revista: Comp Biochem Physiol A Mol Integr Physiol Asunto de la revista: BIOLOGIA MOLECULAR / FISIOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos